RHY 0.00% 10.0¢ rhythm biosciences limited

Sept '21 Deloitte's review of the National Bowel Cancer Screening Program, page-4

  1. 1,604 Posts.
    lightbulb Created with Sketch. 123
    and a cost-effectiveness analysis is performed using reliable estimates of test sensitivity and specificity,as compared with the current iFOBT."

    The current iFOBT is similar if not better than COLOSTAT. I have advised you before in a previous post but you are all in denial.

    in all of RHY announcements they state the following

    ”Highly Accurate - ColoSTAT® was shown to be 35% more accurate at detecting colorectal cancer than the current market standard Faecal Immunochemical Test (FIT)

    what is the current market standard? Please tell me how it relates to Australia.

    ColoSTAT® was shown to be more accurate at detecting advanced adenomas than the current market standard Faecal Immunochemical Test (FIT)

    More accurate by how much? Is it significant?

    @josiejow37

    RHY compare IFOBT to COLOSTAT from internal company data from study 7. That’s where they get send and spec comparisons from.
    Last edited by borano: 30/01/23
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.000(0.00%)
Mkt cap ! $24.85M
Open High Low Value Volume
10.0¢ 10.0¢ 10.0¢ $5K 50K

Buyers (Bids)

No. Vol. Price($)
2 55913 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 24707 2
View Market Depth
Last trade - 10.08am 05/11/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.